David Katz

4.8k total citations · 2 hit papers
81 papers, 3.6k citations indexed

About

David Katz is a scholar working on Infectious Diseases, Epidemiology and Materials Chemistry. According to data from OpenAlex, David Katz has authored 81 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 20 papers in Epidemiology and 13 papers in Materials Chemistry. Recurrent topics in David Katz's work include Quantum Dots Synthesis And Properties (12 papers), Antibiotic Resistance in Bacteria (12 papers) and Chalcogenide Semiconductor Thin Films (8 papers). David Katz is often cited by papers focused on Quantum Dots Synthesis And Properties (12 papers), Antibiotic Resistance in Bacteria (12 papers) and Chalcogenide Semiconductor Thin Films (8 papers). David Katz collaborates with scholars based in Israel, United States and United Kingdom. David Katz's co-authors include Uri Banin, Oded Millo, Y. Charles Cao, Keith Bush, Nigel C. Cowan, P. Gishen, R. Hesp, Edward H. Oldfield, Hetty L. DeVroom and Taleb Mokari and has published in prestigious journals such as Nature, Physical Review Letters and Nature Medicine.

In The Last Decade

David Katz

79 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells

1997 539 citations David Katz et al. profile →
Identification of atomic-like electronic states in indium arsenide nanocrystal quantum dots

1999 502 citations David Katz et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Katz Israel	30	787	732	571	546	495	81	3.6k
T. Kumagai Japan	39	864 1.1×	606 0.8×	223 0.4×	1.6k 2.9×	341 0.7×	258	5.4k
Yoshiko Yamaguchi Japan	24	359 0.5×	406 0.6×	226 0.4×	1.1k 2.0×	157 0.3×	144	4.6k
Honghua Hu Australia	41	724 0.9×	316 0.4×	416 0.7×	1.1k 2.0×	120 0.2×	141	4.4k
Hajime Goto Japan	31	450 0.6×	268 0.4×	896 1.6×	344 0.6×	65 0.1×	200	3.7k
Makoto Ohashi Japan	30	127 0.2×	239 0.3×	276 0.5×	861 1.6×	556 1.1×	146	3.0k
Mario Luppi Italy	46	376 0.5×	207 0.3×	1.4k 2.5×	722 1.3×	167 0.3×	267	6.9k
Robert Wilson United Kingdom	51	531 0.7×	1.3k 1.8×	1.2k 2.1×	2.0k 3.6×	416 0.8×	207	9.8k
Uwe Müller Germany	35	544 0.7×	128 0.2×	576 1.0×	1.1k 1.9×	155 0.3×	90	4.0k
Kenichi Imai Japan	28	245 0.3×	451 0.6×	533 0.9×	717 1.3×	73 0.1×	155	2.8k
Jun Fukushima Japan	34	610 0.8×	318 0.4×	324 0.6×	1.2k 2.3×	359 0.7×	159	3.9k

Countries citing papers authored by David Katz

Since Specialization

Citations

This map shows the geographic impact of David Katz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Katz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Katz more than expected).

Fields of papers citing papers by David Katz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Katz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Katz. The network helps show where David Katz may publish in the future.

Co-authorship network of co-authors of David Katz

This figure shows the co-authorship network connecting the top 25 collaborators of David Katz. A scholar is included among the top collaborators of David Katz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Katz. David Katz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Katz, David, et al.. (2024). Incorporating clinical and demographic data into the Elixhauser Comorbidity Model: deriving and validating an enhanced model in a tertiary hospital’s internal medicine department. BMC Health Services Research. 24(1). 1523–1523.

Ben‐Chetrit, Eli, et al.. (2024). Chloramphenicol treatment revisited – demographics, clinical characteristics, and outcomes of hospitalized patients. European Journal of Clinical Microbiology & Infectious Diseases. 43(8). 1667–1671. 1 indexed citations

Mendlovic, Joseph, Todd Zalut, Gabriel Munter, et al.. (2021). Mixed effect of increasing outflow of medical patients from an emergency department. Israel Journal of Health Policy Research. 10(1). 59–59. 3 indexed citations

Alpert, Evan Avraham, et al.. (2021). Maximizing the Role of Emergency Medical Services in COVID-19 Response. Disaster Medicine and Public Health Preparedness. 17. e87–e87. 4 indexed citations

Macdougall, Colin, Peter Dangerfield, David Katz, & W. David Strain. (2020). The impact of COVID-19 on Medical education and Medical Students. How and when can they return to placements?. SHILAP Revista de lepidopterología. 9. 159–159. 13 indexed citations

Adler, Amos, David Katz, & Dror Marchaim. (2020). The Continuing Plague of Extended-Spectrum β-Lactamase Producing Enterbacterales Infections. Infectious Disease Clinics of North America. 34(4). 677–708. 15 indexed citations

Zaidenstein, Ronit, et al.. (2020). The impact of improper empirical usage of antipseudomonals on admission to an acute care hospital. Journal of Global Antimicrobial Resistance. 22. 5–8. 4 indexed citations

Ben-David, Debby, et al.. (2020). Antimicrobial use for asymptomatic bacteriuria—First, do no harm. Infection Control and Hospital Epidemiology. 42(1). 37–42. 5 indexed citations

Katz, David, et al.. (2019). Correlates of non-typhoidal Salmonella bacteraemia: A case–control study. International Journal of Infectious Diseases. 81. 170–175. 13 indexed citations

10.

Katz, David, et al.. (2016). Diabetic foot infection in hospitalized adults. Journal of Infection and Chemotherapy. 22(3). 167–173. 20 indexed citations

11.

Rehm, Susan J., et al.. (2009). Community-based outpatient parenteral antimicrobial therapy (CoPAT) for Staphylococcus aureus bacteraemia with or without infective endocarditis: analysis of the randomized trial comparing daptomycin with standard therapy. Journal of Antimicrobial Chemotherapy. 63(5). 1034–1042. 47 indexed citations

12.

Martone, W. J., Kimberly C. Lindfield, & David Katz. (2008). Outpatient parenteral antibiotic therapy with daptomycin: insights from a patient registry. International Journal of Clinical Practice. 62(8). 1183–1187. 42 indexed citations

13.

Krige, J E J, Kimberly C. Lindfield, Lawrence V. Friedrich, et al.. (2007). Effectiveness and duration of daptomycin therapy in resolving clinical symptoms in the treatment of complicated skin and skin structure infections. Current Medical Research and Opinion. 23(9). 2147–2156. 16 indexed citations

14.

Katz, David, et al.. (2003). Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) CS6 antigen. Vaccine. 21(5-6). 341–346. 88 indexed citations

15.

Houng, Huo‐Shu H., et al.. (2001). Development of a ceuE-based multiplex polymerase chain reaction (PCR) assay for direct detection and differentiation of Campylobacter jejuni and Campylobacter coli in Thailand. Diagnostic Microbiology and Infectious Disease. 40(1-2). 11–19. 29 indexed citations

16.

Shorr, Andrew F., Alexander S. Niven, David Katz, Joseph M. Parker, & Arn H. Eliasson. (2000). Regulatory and Educational Initiatives Fail to Promote Discussions Regarding End-of-Life Care. Journal of Pain and Symptom Management. 19(3). 168–173. 22 indexed citations

17.

Reeve, J., et al.. (1990). Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride.. BMJ. 301(6747). 314–318. 94 indexed citations

18.

Sambrook, Philip N., R. Hesp, Joan M. Zanelli, et al.. (1990). Rapid periarticular bone loss in rheumatoid arthritis. Arthritis & Rheumatism. 33(5). 615–622. 21 indexed citations

19.

Allason-Jones, E, Adrian Mindel, P.G. Sargeaunt, & David Katz. (1988). Outcome of untreated infection with Entamoeba histolytica in homosexual men with and without HIV antibody.. BMJ. 297(6649). 654–657. 49 indexed citations

20.

Thomas, Elizabeth, et al.. (1979). Upper gastrointestinal hemorrhage in patients with alcoholic liver disease and esophageal varices. Sources, outcome and short-term impact on liver function.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 72(6). 623–9. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact